Moreover, technological advancements in product developmentand related product approvals by the government are another key factor that isresponsible for the growth of the Global Vitreoretinal Surgery Devices market insights.
For instance, in July 2019 Bausch + Lomb announced the launch of the FreeFlow infusion system for retina surgery and the 23-gauge Bi-Blade dual-port vitrectomy cutter for the Stellaris Elite vision enhancement system. This kind of development provides the surgeons with great control during their high flow vitrectomy procedures. Such technological advancements are expected to contribute to the Vitreoretinal Surgery Devices market.
Further, the outbreak of the COVID-19 pandemic led to thecancellation of outpatient visits and the suspension of non-emergency hospitalprocedures. This resulted in the reduced number of routine clinical examinations of the ophthalmic and related procedures.
However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape which has initiated the process of resumption of regular healthcare services such as outpatients visits, thereby bringing the demand for products on track in the Vitreoretinal Surgery Devices market.
Do you know about Vitreoretinal Surgery Devices Market Companies?
However, postoperative complications associated withVitreoretinal Surgery Devices and retinal toxicity of medical devices usedduring Vitreoretinal Surgery may be certain impeding factors to Vitreoretinal Surgery Devices market growth.
Vitreoretinal Surgery Devices Market Segment Analysis:
Vitreoretinal Surgery Devices Market By Type (SurgicalPacks, Systems, Accessories, and Disposables), By Product Type(Photocoagulation Surgery Devices, Vitrectomy Systems, Illumination Surgery Devices, Vitreoretinal Prefilled Silicone Oil Syringes, Others), By End-User (Hospitals, Ophthalmology Clinics, Ambulatory Surgical Centres), By Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the type segment of the Vitreoretinal Surgery DevicesMarket, the Systems are expected to hold a significant share during theforecast period. This can be ascribed to the fact that these are being more preferred by end-users over conventional Vitreoretinal Surgery Devices because these devices have now been redesigned and come integrated with laser control functions and greater light output.
Furthermore, the major players are also marketingadvantageous products such as an ultra-short vitrectomy kit that includes atrocar/cannula that is shorter, and stiffer, and a light pipe that is brighter, which ultimately eases the process during surgery. Also, these innovations allow the real-time display of parameters on the monitor. Therefore, the advantages offered by the Systems are predicted to aid in the growth of the Vitreoretinal Surgery Devices market forecast during the forecast period.
Latest Pharmaceuticals Reports by Delveinsight
Comments